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Abstract: Due to the incompleteness of animal genome sequencing, the analysis and 
characterization of serum proteomes of most farm animals are still in their infancy, 
compared to the already well-documented human serum proteome. This review focuses on 
the implications of the farm animal serum proteomics in order to identify novel biomarkers 
for animal welfare, early diagnosis, prognosis and monitoring of infectious disease 
treatment, and develop new vaccines, aiming at determining the reciprocal benefits for 
humans and animals. 
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1. Introduction 
Proteomics aims at identifying, quantifying, and characterizing the structure and functions of all 
proteins in a living organism, as well as assessing the modulation of these properties based on space, 
time, and physiological state. 
Proteomic approaches on farm animal serum/plasma samples were applied with the purpose of 
certifying animal welfare in order to prevent a negative impact on human health (resulting in reciprocal 
benefits for humans and animals) and improve clinical management and treatment of human diseases [1] 
(Figure 1). Unfortunately, due to the lack of a complete characterization of animal genomes and the 
incomplete annotation of gene functions, studies on farm animal serum proteome are still in their 
infancy, compared to the fully mapped human serum proteome [2]. As shown in the next sections,  
to circumvent this problem, different strategies were applied by using homology searches or human 
annotations of BLAST-searched primary data. 
Figure 1. Routinely pre-analytical and analytical approaches for farm animal serum 
proteomic studies. Serum samples could be pre-treated (A) to reduce the high dynamic 
range in protein concentration, or not pre-treated (B,C) and, subsequently, analyzed 
through electrophoretic, chromatographic and mass spectrometric platforms. The large 
amount of data produced are, then, processed by sophisticated bioinformatic algorithms for 
qualitative and quantitative proteomic analysis. 
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Owing to the high dynamic range of serum samples (spanning ten orders of magnitude [3]) and the 
limited dynamic range of the analytical instrumentations (spanning five orders of magnitude [4]),  
the pre-analytical phase in animal serum proteomics field could play a crucial role in reducing the 
differences in serum protein concentration. Therefore, two serum pre-treatment methodologies have 
been applied for protein immuno-depletion (ID) [5], serum proteome equalization and low-abundance 
protein enrichment (combinatorial peptide ligand libraries technique (CPLL)) [6–8]. More than 90% of 
the serum proteome is represented by less than 10 different proteins (albumin, IgG, α1-antitrypsin, 
IgA, transferrin, etc.). Based on the high specific antibody, ID represents a very effective pre-analytical 
technique able to bind and remove any protein from the animal sera in a very effective manner. 
The major criticisms of the ID technique are represented by the lack of suitable antibodies for all 
animal species and the accidental co-depletion of untargeted proteins [9]. Additionally, recent reports 
have strongly challenged such a protocol, stating that it might not enable access to the low-abundance 
proteome [10]. 
CPLL technique is able to significantly reduce the dynamic concentration range of the animal sera 
normalizing the concentration of the low-abundance proteins to those of the high abundance. Some 
weakness of the CPLL technique comprise the exclusion of the highly hydrophilic proteins from the 
capture event as well as the exclusion of other proteins designed as aberrant because they behave in an 
unpredictable way. 
Both these techniques were successfully applied on the farm animal serum samples. The analytical 
phase includes proteomic approaches based on the electrophoretic, chromatographic and mass 
spectrometric technologies. In the field of animal serum proteomics both qualitative and quantitative 
methods have been applied, by using gel-based and gel-free mass spectrometry (MS) approaches. 
The aim of qualitative proteomic analysis is to describe the proteins and their post translational 
modifications in serum samples, related to a specific patient status. The most widely used MS 
approach for in-depth serum protein identification is represented by the shotgun proteomics. It is a  
gel-free proteomic approach in which, after a total proteome enzymatic digestion, the produced 
peptides are separated with a high resolution liquid chromatography (LC) system and identified using 
tandem mass spectrometry (MS/MS) and automated database searching [11]. Qualitative analysis  
have also been performed by gel-based proteomic approaches, using one-dimensional (1-DE) and  
two-dimensional (2-DE) gel electrophoresis for protein purification and, LC–MS/MS or matrix 
assisted laser desorption ionization-time of flight-MS (MALDI-TOF-MS) [12] and automated database 
searching for a subsequent protein identification of the in-gel digested proteins. 
Mass spectrometry based quantitative proteomics can be classified in relative and absolute 
measurements [13]. Aim of the relative quantification is establishing the modulations in protein 
expression between two (or more) serum proteomes (i.e., healthy versus pathological subjects).  
Conversely, the absolute quantification aims at quantifying the amount of proteins/peptides into  
serum samples. 
Animal serum proteomes have been analyzed only by using relative protein quantification 
approaches by: (i) gel-based platforms, 2-DE to compare spot patterns from different serum samples 
and two-dimensional differential gel electrophoresis (2D-DIGE) [14] to assess protein profile changes 
from two or three serum samples runs on a single 2D-gel; (ii) gel-free platforms represented by stable 
isotope based (Figure S1) and label-free methods. The first ones (ICAT [15] and iTRAQ [16], applied 
Int. J. Mol. Sci. 2014, 15 15399 
 
 
in the animal serum proteomic field, use stable isotopes to label digested proteins, introducing a mass 
variation between the labeled and unlabeled peptides in the process. The intensity signals obtained 
from the unlabeled and labeled peptide will then provide quantitative information in the MS spectrum. 
Label-free methods [17] do not introduce labels and rely on chromatographic and MS data to 
quantify peptides in the samples. In this approach the separate LC–MS/MS runs of samples in different 
states are aligned and the quantitative analysis of protein concentrations is performed by calculating 
the area or the intensity of peaks of the same peptide in the two runs. 
A very useful quantitative and qualitative MS method in the farm animal serum proteomic field is 
the surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry. 
It combines two powerful techniques: chromatography to retain the proteins on a solid-phase 
chromatographic surface and MS to detect them by a TOF MS. SELDI-TOF is a profiling technique 
that, based on the relation between patient and control sera protein profiles, allows the identification of 
MS signals of potentially disease biomarkers. It represents a complementary visualization technique  
to 2-DE [18]. 
Animal Genome Databases and Annotation of Gene Functions 
As mentioned above, studies on animal serum samples have to deal with the partial characterization 
of animal genomes and the incomplete annotation of gene functions. 
The main protein sequence and Gene Ontology (GO) Annotation consortium is Uniprot-GOA that 
is implicated in the cure of GO annotation program [19]. An application of GO is the creation of gene 
product annotations, based on literature evidences or sequence-based analysis. Actually, GO 
Consortium (GOC) has annotated about 100 million GO terms covering >400,000 species, including 
all the kingdoms of life. This number includes two classes of GO annotations: those created manually 
by reviewing the literature and those generated computationally via automated methods [20].  
Uniprot provides the “complete proteome” for Homo Sapiens and “partially complete proteome” for  
Gallus Gallus, Bos Taurus, and Sus Scrofa. These well studied model organisms represent reference 
proteomes in several biomedical researches. 
GOC aim is the development of a unique nomenclature, describing the functional characteristics 
(Molecular Function, Biological Process, Cellular Component) of any gene product from any  
organism [21]. 
The number of assigned GO terms to gene products and the number of distinct protein of human 
and main farm animals are showed in Table 1. The annotation data in GO database should contain 
information about the source (protein databases) and the evidence of implication in a specific 
biological process. The number of terms associated to a specific organism is then strictly related to the 
number of entries of gene products. Only few animal databases are quite complete and this is the main 
limit to describe the output of proteomic analyses of animal serum related to human serum. 
However, even if there are some lacks in the full description of animal proteomes, their characterization 
is possible thanks to the use of reference proteome databases, homology searching (BLAST searching) 
and to interfere the reference GOA databases with experimental animal data. One of GO’s main uses 
is, in fact, to perform enrichment analysis on gene sets. For example, given a set of genes that  
are up-regulated under certain conditions, an enrichment analysis will find which GO terms are  
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over-represented (or under-represented) using annotations for that gene set. There are a number of 
different tools that provide enrichment capabilities. Some of these are web-based, others may require 
the user to download an application or install a local environment. Tools differ in the algorithms they 
use, and the statistical tests they perform. Some other examples of enrichment tools are: gProfiler; 
BiNGO; Ontologizer and Cytoscape. 
Table 1. Gene Ontology (GO) annotations of main farm animal species. 
GO Annotation Number of Associations Number of Distinct Proteins 
Human 403,735 46,159 
Chicken 93,784 14,238 
Cow 128,684 20,032 
Pig 107,097 19,723 
2. Animal Serum Proteomic Applications 
As shown in Table 2, this article focuses on farm animal serum proteomics, aiming at determining 
the reciprocal benefits for humans and animals. 
Table 2. Some applications of serum proteomic approaches in the veterinary field. 
Farm Animals Proteomic Techniques Serum Proteomics Study Reference 
  
Bovine 
2D-DIGE  
MALDI-TOF-MS  
MS/MS 
Serum proteomic analysis of Bruna cows to identify novel 
potential biomarkers for stress and welfare 
[22] 
MALDI-TOF-MS 
Production of reproducible protein mass profiles able to 
identify calves undergoing illicit treatments 
[23] 
2D-DIGE  
MALDI-TOF-MS 
Investigation of new pathophysiological modulations in the 
plasma proteome of cows affected by milk fever 
[24] 
2-DE  
MS 
Study of serum proteome modulations of heifers during the 
last phase of pregnancy and early postpartum as a tool for 
the most accurate management of the peripartum period of 
these animals 
[25] 
1-DE  
MALDI-TOF-MS 
Identification of 480 bovine plasma proteins [26] 
MALDI-TOF-MS  
2-DE 
Serum proteomics evaluation of cows for a better 
understanding of mastitis pathophysiology and an early 
diagnosis of the disease 
[27,28] 
iTRAQ  
MS 
Study of cattle serum samples infected with either 
Mycobacterium bovis or Mycobacterium paratuberculosis 
for discovery of potential biomarkers of infection and 
progression of disease 
[29] 
CPLL  
2D-DIGE  
LC–MS/MS 
Early diagnosis of bovine Johne’s disease [30] 
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Table 2. Cont. 
Farm Animals Proteomic Techniques Serum Proteomics Study Reference 
  
Bovine 
MALDI-TOF-MS  
2-DE 
Proteome and immunome of the tachyzoite stage of 
Besnoitia besnoiti in bovine besnoitiosis to study 
significant biological processes and host immune response 
associated with parasite infection 
[31] 
  
Ovine 
2-DE  
MALDI-TOF-MS 
Identification of novel staphylococcal antigens for rational 
vaccine design 
[32] 
2-DE 
Serological proteome analysis for the identification of 
Staphylococcus aureus antigens produced in the sheep 
immune response during mastitis 
[33] 
SELDI-TOF-MS  
1-DE  
LC–MS/MS 
Identification of biomarkers in sheep paratuberculosis [34] 
SELDI-TOF-MS 
Detection of a panel of 4 putative serum protein biomarkers 
as immunological responses in infectious diseases in sheep  
[35] 
2-DE  
MALDI-TOF-MS 
Application of proteomics in putative biomarker  
discovery for early diagnosis as well as for monitoring  
the physiological and metabolic situations critical for  
ovine welfare 
[36] 
  
Swine 
2D-DIGE  
MS 
Evaluation of the validity of traditional stress biomarkers in 
pigs housed at different densities and identification of new 
potential stress biomarkers 
[37] 
2-D-DIGE  
MALDI-TOF-MS  
LC–MS/MS 
Identification of 10 differentially expressed protein spots by 
analysis of the serum proteome modulations in pigs 
infected by CSF virus versus uninfected controls 
[38] 
LC–MS/MS 
Identification of altered pigs serum proteome with  
FMD virus infection by analyzing the pigs before  
and after infection 
[39] 
LC–MS/MS  
Assessment of serum proteome profiles modulation 
between Ossabaw pigs and human NAFLD 
[40,41] 
  
Poultry 
2-DE  
MALDI-TOF-MS 
Analysis of serum proteome of hens at different 
developmental stages as a base to explore the physiology of 
growth or reproduction of laying hens 
[42] 
2-DE  
LC–MS/MS  
Evaluation of APEC proteome changes after exposure to 
chicken serum to characterize specific protein molecules 
that may be involved in serum resistance of APEC isolates 
[43] 
1-DE  
MALDI-TOF-MS 
Evaluation of APEC growth in different host species 
requires different survival strategies 
[44] 
2-DE,  
MALDI-TOF-MS 
Evaluation of the serum proteome from broilers inoculated 
with one Eimeria species 
[45] 
  
Equine 
1-DE  
MALDI-TOF-MS  
MS/MS 
Serum proteome evaluation of the effects of  
Senecio jacobea ingestion by horses 
[46] 
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Table 2. Cont. 
Farm Animals Proteomic Techniques Serum Proteomics Study Reference 
  
Equine 
MALDI-TOF-MS  
LC–MS/MS 
Characterization of 29 different serum proteins to establish 
a horse serum protein database and acquire a better 
knowledge on equine proteome modulation during diseases 
[47] 
SELDI-TOF-MS 
MALDI-TOF-MS  
Evaluation of differences in serum proteome profiles of 
horses, donkeys and mules to determine possible 
metabolism-related differences 
[48] 
2D-DIGE  
MALDI-TOF-MS 
Discovery of 7 potential biomarker candidates to improve 
diagnosis and therapy of autoimmune uveitis  
[49] 
  
Fish 
Capillary 
Electrophoresis–MS 
Description of the N-glycans level in serum of salmon 
(Salmo salar) exposed to long-term handling stress 
[50] 
2-DE  
LC–MS/MS  
Assessment of the increase of lysozyme and angiotensin 
carboxypeptidase activities in plasma of fish transferred 
from hypoosmotic to hyperosmotic solution 
[51,52] 
2-DE  
MALDI-TOF-MS  
Determination of protein profiles of alterations in serum of 
rainbow trout (Oncorhynchus mykiss, Walbaum) as a 
measure of the acute phase response to the probiotics 
present in the feed 
[53] 
2-DE  
MS/MS 
Characterization of the alterations in serum acute phase 
response-related proteins with low molecular weight from 
loach after injury 
[54] 
1-DE  
MALDI-TOF-MS 
The first heterogeneous interactome between  
shrimp serum proteins and Vibrio parahaemolyticus  
outer membrane proteins 
[55] 
Abbreviations: MALDI-TOF-MS, matrix assisted laser desorption ionization-time of flight-mass spectrometric;  
1-DE, one-dimensional electrophoresis; 2-DE, two-dimensional electrophoresis; 2D-DIGE, two-dimensional 
differential gel electrophoresis; SELDI-TOF-MS, surface-enhanced laser desorption/ionization time-of-flight 
mass spectrometry; LC–MS/MS, liquid chromatography–tandem mass spectrometry; CPLL, combinatorial 
peptide ligand libraries technique; CSF, classical swine fever; NAFLD, nonalcoholic fatty liver disease. 
2.1. Monitoring of Animal Welfare 
The expression “animal welfare” indicates their physical and psychological wellbeing. The assessment 
of animals’ wellbeing actually relies on behavioral tests (for most farm animals) which are easy to 
perform, or on measurement of stress markers like cortisol, also easy to measure but panels of 
biomarkers to associate each stress condition to physical and psychological state are desirable. 
As described below, considerable experimental work, based on proteomics of farm animal serum, 
has been performed in order to assess the animals’ welfare by monitoring stressful states associated 
with their farming, food safety patho-physiological state and reproduction conditions. At present, these 
protein markers donot replace older routinely tests because they have yet to be validated. 
Farms with insufficient space and difficult environments can stimulate a constant stress condition 
that alters the activity of the pituitary-adrenal axis with relapses on behavior, reproduction and food 
product quality [56–58]. 
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To this purpose, different farm animal species represented by pig, cow and fish were studied.  
By using 2D-DIGE, immunoblotting, and MS technologies, Marco-Ramell et al. [37] assessed the 
validity of traditional stress biomarkers in pigs housed at different densities, identifying the actin as a 
novel potential stress biomarker and proposing cholesterol, pig-major acute phase protein, oxidative 
stress marker and cortisol as a molecular profile of the stress conditions in pigs. 
Subsequently, with the same aim, the authors identified antioxidant enzymes, such as glutathione 
peroxidase, α2 Heremans Schmid glycoprotein, cholesterol, and fecal corticosterone, as novel potential 
biomarkers for monitoring the adaptation process of Bruna cows to difficult environments [22]. 
Moreover, Liu et al. [50], for the first time, described the N-glycans level in salmon serum (Salmo salar) 
exposed to long-term handling stress (15 s out of the water daily, for four weeks), compared with  
fish control sera. The results showed that the 83% of N-glycans in salmon serum is formed by  
mono-acetylated sialic acids, and the O-acetylation pattern of sialic acids was indeed altered by the 
handling stress. Finally, Jiang et al. [51] and Kumar et al. [52] revealed that plasma lysozyme and 
angiotensin carboxypeptidase activities were significantly enhanced in fish transferred from hypoosmotic 
to hyperosmotic solution. 
Many other proteomic approaches were applied on cow serum samples to obtain results able to 
assess the bovine welfare. It is well known that performance enhancing agents are illegally used in 
animals, in order to increase lean meat production; however, these illicit substances could produce 
serious state of stress in the meat animals. Owing to the very low dosage and the use of 
uncharacterized new chemical agents, the identification of these molecules by conventional analytical 
approaches is challenging. This scenario encouraged a strong interest in the development of new and 
efficient molecular biomarkers for the detection of growth promoting agents in animals raised for meat 
production. In this regard, Della Donna et al. [23] developed a multivariate MALDI-TOF-MS 
proteomics platform, creating reproducible protein mass profiles from small volumes of serum 
samples, to identify calves undergoing illicit treatments. This pioneering work provided evidence  
of the potential application of MALDI-TOF-MS proteomic profiling in the food safety control.  
Xia et al. [24] investigated the plasma proteome of cows affected by milk fever (a disease of dairy 
cows characterized by reduced blood calcium levels, causing a state of stress and production of  
low quality milk) and identified the pathophysiological modulations of angiotensin, endopin 2B, 
albumin, fibrinogen β chain and IgG heavy-chain C-region by using DIGE technology, followed by  
MALDI-TOF proteins identifications. 
Cairoli et al. [25] highlighted modulations in the serum proteome of heifers, to improve 
management of their peripartum period and, finally, for in-depth bovine plasma proteome 
characterization, Henning et al. [26] applied CPLL technology and three complementary fractionation 
strategies (SDS-PAGE, gel-free protein isoelectrofocusing or gel-free peptide isoelectrofocusing), 
identifying 480 bovine plasma proteins. 
The application of proteomic technologies on horse serum samples produced different results in 
order to monitor equine welfare. Moore et al. [46] evaluated the effects of the ingestion of the  
Senecio jacobea (a poisonous weed ragwort very dangerous in hay) by horses, highlighting the 
presence of pyrrolizidine alkaloid toxins that are subsequently metabolized to cytotoxic pyrroles, 
which can bind proteins. They showed the modifications of equine plasma proteins with pyrrolic 
metabolites using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and MS as 
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proteomics platforms. This model could be a new proteomic approach aimed at identifying potential 
protein biomarkers of ragwort exposure in horses and other livestock. 
By establishing equine serum protein databases and by collecting knowledge on proteome 
modulation during diseases, Miller et al. [47] identified different serum proteins from different horse 
breeds by using 2-DE and MALDI-TOF-MS. Conversely, Henze et al. [48] evaluated the differences 
in serum proteome profiles of horses, donkeys, and mules, using SELDI-TOF technology and 
highlighted changes in posttranslational modifications (PTMs) of the protein transthyretin by using 
immunoprecipitation and MALDI-TOF-MS. 
Fish serum proteomic studies also produced important results. Brunt et al. [53] applied proteomic 
platforms based on 2-DE and MALDI-TOF-MS to analyze the alterations of protein profiles in serum 
of rainbow trout (Oncorhynchus mykiss, Walbaum), as a measure of the acute phase response to 
probiotics Aeromonas sobria GC2 and Bacillus sp. JB-1, present in the feed. Wu et al. (2004) [54] 
applied 2-DE with Tris–tricine gel system, peptide mass fingerprinting and MS/MS proteomic 
platforms to characterize the alterations in serum of low molecular weight acute phase proteins in 
loach after injury. In this experimental work, the authors highlighted the up-regulation of C-reactive 
protein and gastrin 71, the down-regulation of apolipoprotein and the disappearance of parvalbumin in 
serum from loach following injury with respect to control fish. 
Finally, serum proteomic strategies have been applied by Huang et al. [42] in order to investigate 
the changes in proteome of laying hens at different developmental stages. 
2.2. Monitoring of Diseases 
Infectious diseases of animals are caused by pathogenic agents, such as bacteria, viruses, protists, 
and represent a major health threat. 
Proteomic strategies have been applied on serum samples from bovine, ovine, swine, poultry, 
equine, and fish, to identify novel biomarkers for early diagnosis, prognosis, assessment and treatment 
monitoring of infectious diseases and to best understand their pathogenetic mechanisms and develop 
new treatments. 
2.2.1. Bovine Serum Proteomics 
One of the first samples of applied infectious proteomic study is the analysis of bovine mastitis that 
causes decreased milk production and, therefore, economic damage to the industry. Bovine mastitis is 
an infectious disease, whose transmission is strongly influenced by factors related both to animals 
(breed, parity, stage of lactation, production level, morphological characteristics) and farming 
conditions (farm hygiene, presence of litter, conditions and maintenance of the milking machine, 
correct milking execution). Some bacteria involved in mastitis can cause serious human diseases. 
Moreover, treatment of the animal disease can result in the presence of antibiotic residues in milk, 
causing allergic sensitization or inducing antibiotic resistance in humans. The proteomic differential 
approach has been used in several works obtaining appreciable results [27]. In particular, the analysis 
of health bovine serum and mastitis serum by using 2-DE followed by MALDI-TOF-MS, allowed the 
authors to obtain disease-specific protein maps to monitor the course of the disease and the response  
to treatment [28]. 
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Other bovine infectious diseases, that have been characterized by a proteomic approach,  
are tuberculosis, Johne’s disease (JD) and besnoitiosis. The bovine tuberculosis represents a  
highly prevalent zoonotic infection in cattle worldwide, caused by the intracellular bacterium 
Mycobacterium bovis (MB). Looking for an early detection of MB infection, Seth et al. [29] identified 
new protein biomarkers using iTRAQ on cattle serum samples infected with either MB or 
Mycobacterium paratuberculosis (MP). 
JD is a worldwide common and economically relevant chronic inflammatory pathology of the  
small intestine of ruminants caused by Mycobacterium avium subspecies paratuberculosis (MAP). 
Moreover, numerous technological approaches currently available for JD diagnosis have a limited 
sensitivity. To this purpose, You et al. [30] applied CPLL, 2D-DIGE, and LC–MS/MS, to detect 
protein biomarkers of MAP infection in cows. 
Finally, Bovine besnoitiosis (BB), a re-emergent disease in Europe, also present in Africa and Asia, 
is caused by the cyst-forming apicomplexan parasite Besnoitia besnoiti and is responsible for severe 
economic losses. However, the disease molecular mechanisms and parasite biology have still to be 
clarified. García-Lunar et al. [31] conducted a proteomic study to describe the proteome and 
immunome of the tachyzoite stage of BB using 2-DE, immunoblotting and MALDI-TOF/TOF MS. 
They found several proteins, five of which were cross-reactive antigens between BB and N-caninum. 
They also investigated both the relevant biological processes and the host immune response associated 
with the parasite infection. 
2.2.2. Ovine Serum Proteomics 
Staphylococcus aureus mastitis can also adversely affect the production of sheep’s milk. 
Unfortunately, antibiotic treatment and prophylactic measures, including the development of  
an effective vaccine, so far have proven to be ineffective tools for the control of this disease.  
In this regard, Vytvytska et al. [32] and Le Maréchal et al. [33] applied 2-DE, immunoblotting and  
MALDI-TOF-MS proteomic approaches for the identification of novel staphylococcal antigens for 
rational vaccine design. 
Zhong et al. [34] applied SELDI MS, SDS-PAGE, and LC–MS/MS technologies on sheep whole 
serum infected with MAP and identified transthyretin and α-haemoglobin as putative biomarkers. 
Some papers have been published on the characterization of the early detection of the immunological 
responses in viral and bacterial infections in sheep using SELDI-TOF, 2-DE and MALDI-TOF/TOF 
MS techniques on sera. The results showed different up- and down-regulated proteins, related to 
controls that could be potential biomarkers [35,36]. 
2.2.3. Swine Serum Proteomics 
Sun et al. [38] analyzed the serum proteome modulations in pigs infected with classical swine fever 
virus, using 2-D DIGE followed by MALDI-TOF-MS or LC–MS/MS. They identified 10 differentially 
expressed protein spots, potentially biomarkers for the early diagnosis of the disease. Another serious 
infectious disease is foot-and-mouth disease (FMD) that affects cloven-hoofed animals. The virus 
causes high fever and produces blisters inside the mouth and on the feet that may break, thus causing 
lameness. FMD can affect humans but it is not dangerous for their health. Liu et al. [39] reported the 
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first qualitative serum proteomic analysis from pigs before and after induced infection by FMD virus 
using LC–MS/MS. They developed novel drug targets and new biomarkers for care and early 
diagnosis of FMD and elucidated some mechanisms of the FMD virus pathogenesis. 
Some human diseases can also be studied in animal models in order to compare the results with 
those from human studies and best understand the pathogenetic mechanisms and develop new 
treatments. The main limitation of this approach is related to the transferability of data between  
animal species. In fact, homologous proteins could have different post translational modifications and, 
therefore, different interaction protein patterns and biological functions, too. 
Nonalcoholic fatty liver disease (NAFLD) is a common chronic disorder that occurs in the absence 
of significant alcohol abuse [59]; its pathogenesis has not yet been fully clarified. Appropriate animal 
models can help analyze the molecular mechanisms and identify new biomarkers for early detection 
and therapy monitoring. In this regard, Lee et al. [40] and Bell et al. [41] created a nutritional model of 
NASH (non-alcoholic steatohepatitis) and metabolic syndrome in miniature Ossabaw pigs very similar 
to human NASH and, using label-free quantitative proteomics approach, they assessed the modulation 
of serum proteomic profiles in animal and human NAFLD. The authors recommend the use of this pig 
model to improve knowledge on NASH and related metabolic abnormalities. 
2.2.4. Poultry Serum Proteomics 
Each year the poultry industry suffers from consistent financial losses due to Colibacillosis disease, 
caused by an avian pathogenic Escherichia coli (APEC) that mainly affects broiler chickens resulting 
in septicemia and death. Using a proteomic approach, Tyler et al. [43] characterized specific proteins 
possibly involved in serum resistance of APEC isolates. In this study, the serum proteins were purified 
and separated by 2-DE approach; subsequently, ten protein spots, corresponding to eight differentially 
expressed proteins (some of them previously associated with E. coli virulence) were selected and 
characterized by LC–MS/MS. This pivotal study represented the precursor of future proteomic 
applications to identify the key players in serum resistance of APEC. 
Later, Li et al. [44], using SDS-PAGE and MALDI-TOF/TOF-MS, compared the APEC proteome 
from human and avian sera, to determine growth in different host species and assess different survival 
strategies. In response to both human and avian sera, proteins contributing to active iron scavenging 
were up-regulated in APEC. Interestingly, these data support the concept that both human and avian 
sera are iron-limited environments. 
Coccidiosis disease is characterized by destruction of the mucosa and is caused by Eimeria species, 
a protozoan responsible for a host- and infection site-specific intestinal disease. Two-DE, followed by 
MALDI-TOF/TOF MS were used to assess the serum proteome of broilers, after Eimeria acervulina 
inoculation. The identification of proteins that significantly changed in response to the infection allowed 
to highlight host response to coccidiosis and identify diagnostic and pharmacological targets [45]. 
2.2.5. Equine Serum Proteomics 
Proteomic strategies based on 2D-DIGE and MALDI-TOF approaches have been applied on 
healthy and uveitis-affected horse serum samples, with the aim of identifying seven biomarker 
candidates for the diagnosis of autoimmune uveitis [49]. 
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2.2.6. Fish Serum Proteomics 
The mass spectrometry based proteomics have been applied by Liu et al. [55] to evaluate the first 
heterogeneous interactome between shrimp serum proteins and Vibrio parahaemolyticus outer membrane 
proteins; their results indicated that a complex network is formed when microbes invade the host. 
3. Conclusions and Future Perspectives 
Proteomics could help evaluate the farm animal welfare, reduce the risk of zoonoses and improve 
quality and safety of animal products while reducing financial losses. 
During the last decade, the development of standard pre-analytical sample treatments, MS-based 
technologies and data processing systems for data management, have designated proteomics as a major 
platform to interrogate the plasma/serum proteome for discovery of next-generation biomarkers in the 
human and veterinary field. Due to the high number of serum proteins that may be simultaneously 
investigated, this approach is faster than ELISA and PCR techniques. The high initial investment 
required to buy the equipment represents a major limitation to a more widespread use of the technique. 
However, the costs involved are rapidly falling, thus, favoring its purchase. New proteomic 
technologies may dramatically improve discovery of next-generation biomarkers supporting diagnosis 
and monitoring of a variety of diseases in human and farm animals. 
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